Our products

Here we show the Russian type of packaging because there are diverse requirements in different countries regarding the packaging design.

Cortexin®

Over the last decade, neurologists and other doctors have witnessed the increasing use of Cortexin - a new home-produced peptide drug. Its use has become possible after the discovery of low molecular peptides,which convey the information necessary for normal functioning, interaction and development of cells. The discovery of these peptides underlay a search and development of new pharmacological agents. Cortexin use is based on the ability of the drug to provide a normalizing effect on many functions of the brain.

“Geropharm” is the sole manufacturer of Cortexin, the original drug. (Link to the web of the Federal Service for Supervision in the Sphere of Health Care and Social Development- http://www.roszdravnadzor.ru/registration/ls/spis). The drug is produced with the Company’s own patented technology.

Registration number

In the instruction posted to this website, we do not show the drug registration number, because in each country there are different regulations and different assigned numbers.

Date of registration

In the instruction posted to this website, we do not show the date of registration, because in each country there are different regulations and different assigned numbers.

Commercial name

CORTEXIN®

Grouping name

Cattle cerebral cortical polypeptides.

Dosage form

lyophilisate for preparation of solution for intramuscular injections.

Composition

One vial contains
10 mg of active substance – Cortexin (complex of water-soluble polypeptide fractions),
12 mg of excipient – Glycine (stabilizer).

Description

Lyophilized powder or porous mass, white or white with yellowish tints

Pharmacotherapeutic group

nootropic drug

ATC Code

Characteristics

Cortexin is a complex of water-soluble polypeptide fractions with molecular weight not exceeding 10 000 Da.

Pharmacological effect

Pharmacodynamics

CORTEXIN® contains a complex of low-molecular water-soluble polypeptide fractions, which penetrate the blood-brain barrier and directly affect nervous cells. The preparation has nootropic, neuroprotective, antioxidant and tissue-specific effect. Nootropic effect – improves higher cerebral functions, processes of learning and memory, concentration of attention and tolerance to different stresses.

Neuroprotective effect – protects neurons against different endogenous neurotoxic factors (glutamate, calcium ions and free radicals) and reduces toxic impact of psychotropic agents.

Antioxidant effect – inhibits peroxidation of lipids in neurons, increases survival of neurons under oxidative stress and hypoxia.

Tissue-specific effect – activates metabolism of neurons of central and peripheral nervous system, reparative processes, promotes stimulation of cortical function and general improvement of nervous system state.

Mechanism of action of CORTEXIN® is determined by activation of neuronal peptides and neurotrophic cerebral factors; optimization of metabolic balance of excitatory and inhibitory amino acids, dopamine, serotonin; GABAergic action; reduction of paroxysmal convulsive activity of brain, improvement of its bioelectrical activity; prevention of formation of free radicals (products of lipid peroxidation).

Pharmacokinetics

Composition of CORTEXIN®, which active agent is a complex of polypeptide fractions, does not allow a common pharmacokinetic analysis of separate components to be performed.

Indications

In a complex therapy of disturbances in the blood supply to the brain, craniocerebral trauma and its consequences, different types of encephalopathies, cognitive disorders (dysfunction of memory and ideation), acute and chronic encephalitis and encephalomyelitis, epilepsy, asthenic conditions (suprasegmental autonomic disorders), reduced learning capacity, psychomotor and speech retardation in children, different types of infantile cerebral paralysis.

Contraindications

Individual intolerance.

Pregnancy and lactation

This medical product is contraindicated to pregnant women (due to lack of clinical trial results). If administration during lactation is required, it is necessary to stop breast feeding (due to lack of clinical trial results)

Administration and dosages

For intramuscular injections.

Before injection dissolve content of vial in 1–2 ml of 0.5 % procain (novocain ) solution, or water for injection or 0.9 % sodium chloride solution and inject once daily:

For adults - 10 mg per day, during 10 days; for children weighing less than 20 kg – 0.5 mg/kg, over 20 kg – 10 mg per day, during 10 days.

If necessary, the course is repeated after 3-6 months.

Adverse reactions

No adverse reactions were observed during administration when taken as indicated. Individual hypersensitivity to the product components is possible.

Overdosage

No cases of overdosage were reported.

Interaction with other medicinal preparations

Not described.

How supplied

Lyophilisate for preparation of solution for intramuscular injections, 10 mg. Supplied in 5 ml (10 vials per a cardboard package) with indications on use enclosed.

Storage conditions

Store in a dry place protected from light place, at 2-20 °C. Keep out of reach of children.

Shelf life

Three years. Do not use after expiration of shelf life date indicated on package.

How dispensed

On prescription only.

Manufacturer

OOO GEROPHARM

191119, Russia, Saint Petersburg, Zvenigorodskaya ul. 9

Telephone: (812) 703-79-75 (multiline), fax: (812) 703-79-76

Organization authorized to accept consumers’ claims

OOO GEROPHARM

197022, Russia, Saint Petersburg, ul. Akademika Pavlova 5 V

Telephone: (812) 703-79-75 (multiline), fax: (812) 703-79-76

Hotline: 8-800-333-4376 (free throughout Russia)

www.cortexin.ru

www.geropharm.ru

The drug is a prescription medication. Before use, always consult your physician.